Arcadia Biosciences, Inc. (RKDA) is a Agricultural Inputs company in the Basic Materials sector, currently trading at $1.39. It has a SharesGrow Score of 57/100, indicating a above average investment profile with 3 out of 7 criteria passed.
Analyst consensus target is RKDA = $6 (+331.7% upside).
Valuation: RKDA trades at a trailing Price-to-Earnings (P/E) of -0.8 (S&P 500 average ~25) with a forward Price/Earnings-to-Growth (PEG) of 0.15.
Financials: revenue is $5M, -18.5%/yr average growth. Net income is $2M (loss), growing at +42.3%/yr. Net profit margin is -48.1% (negative). Gross margin is 36.2% (+34.7 pp trend).
Balance sheet: total debt is $0 against $4M equity (Debt-to-Equity (D/E) ratio 0, conservative). Current ratio is 3.09 (strong liquidity). Debt-to-assets is 0%. Total assets: $7M.
Analyst outlook: 4 / 5 analysts rate RKDA as buy (80%) — strong consensus.
SharesGrow 7-Criteria breakdown: Value 100/100 (Pass), Growth 58/100 (Partial), Past 0/100 (Fail), Health 100/100 (Pass), Moat 36/100 (Fail), Future 94/100 (Pass), Income 10/100 (Fail).
